[1]
|
Castiglioni, V., Faedo, A., Onorati, M., Bocchi, V.D., Li, Z., Iennaco, R., et al. (2019) Dynamic and Cell-Specific DACH1 Expression in Human Neocortical and Striatal Development. Cerebral Cortex, 29, 2115-2124.
https://doi.org/10.1093/cercor/bhy092
|
[2]
|
Chang, A.H., Raftrey, B.C., D’Amato, G., Surya, V.N., Poduri, A., Chen, H.I., et al. (2017) DACH1 stimulates Shear Stress-Guided Endothelial Cell Migration and Coronary Artery Growth through the CXCL12-CXCR4 Signaling Axis. Genes & Development, 31, 1308-1324. https://doi.org/10.1101/gad.301549.117
|
[3]
|
Kong, D., Liu, Y., Liu, Q., Han, N., Zhang, C., Pestell, R., et al. (2016) The Retinal Determination Gene Network: From Developmental Regulator to Cancer Therapeutic Target. Oncotarget, 7, 50755-50765.
https://doi.org/10.18632/oncotarget.9394
|
[4]
|
Endlich, N., Kliewe, F., Kindt, F., Schmidt, K., Kotb Ahmed, M., Artelt, N., et al. (2018) The Transcription Factor Dach1 Is Essential for Podocyte Function. Journal of Cellular and Molecular Medicine, 22, 2656-2669.
https://doi.org/10.1111/jcmm.13544
|
[5]
|
Wang, H., Yuan, Q., Sun, M., Niu, M., Wen, L., Fu, H., et al. (2017) BMP6 Regulates Proliferation and Apoptosis of Human Sertoli Cells Via Smad2/3 and Cyclin D1 Pathway and DACH1 and TFAP2A Activation. Scientific Reports, 7, Article No. 45298. https://doi.org/10.1038/srep45298
|
[6]
|
Xu, H., Yu, S., Yuan, X., Xiong, J., Kuang, D., Pestell, R.G., et al. (2017) DACH1 Suppresses Breast Cancer as a Negative Regulator of CD44. Scientific Reports, 7, Article No. 4361. https://doi.org/10.1038/s41598-017-04709-2
|
[7]
|
Xu, H., Yu, S., Liu, Q., Yuan, X., Mani, S., Pestell, R.G., et al. (2017) Recent Advances of Highly Selective CDK4/6 Inhibitors in Breast Cancer. Journal of Hematology & Oncology, 10, Article No. 97.
https://doi.org/10.1186/s13045-017-0467-2
|
[8]
|
Hu, X., Huang, W. and Fan, M. (2017) Emerging Therapies for Breast Cancer. Journal of Hematology & Oncology, 10, Article No. 98. https://doi.org/10.1186/s13045-017-0466-3
|
[9]
|
Xu, H.-X., Wu, K.-J., Tian, Y.-J., Liu, Q., Han, N., He, X.-L., et al. (2016) Expression Profile of SIX Family Members Correlates with Clinic-Pathological Features and Prognosis of Breast Cancer. Medicine, 95, Article No. e4085.
https://doi.org/10.1097/MD.0000000000004085
|
[10]
|
Liu, Q., Li, A., Tian, Y., Liu, Y., Li, T., Zhang, C., et al. (2016) The Expression Profile and Clinic Significance of the SIX Family in Non-Small Cell Lung Cancer. Journal of Hematology & Oncology, 9, Article No. 119.
https://doi.org/10.1186/s13045-016-0339-1
|
[11]
|
Zhao, F., Wang, M., Li, S., Bai, X., Bi, H., Liu, Y., et al. (2015) DACH1 Inhibits SNAI1-Mediated Epithelial-Mesenchymal Transition and Represses Breast Carcinoma Metastasis. Oncogenesis, 4, Article No. e143.
https://doi.org/10.1038/oncsis.2015.3
|
[12]
|
Wu, K., Xu, H., Yuan, X., Tian, Y., Liu, Y., Liu, Q., et al. (2016) Enrichment of CD44 in Basal-Type Breast Cancer Correlates with EMT, Cancer Stem Cell Gene Profile, and Prognosis. OncoTargets and Therapy, 9, 431-444.
https://doi.org/10.2147/OTT.S97192
|
[13]
|
Wu, K., Yu, S., Liu, Q., Bai, X., Zheng, X. and Wu, K. (2017) The Clinical Significance of CXCL5 in Non-Small Cell Lung Cancer. OncoTargets and Therapy, 10, 5561-5573. https://doi.org/10.2147/OTT.S148772
|
[14]
|
Chen, S., Peng, M., Zhou, G., Pu, Y., Yi, M., Zhu, Y., et al. (2019) Long Non-Coding RNA HOTAIR Regulates the Development of Non-Small Cell Lung Cancer through miR-217/DACH1 Signaling Pathway. European Review for Medical and Pharmacological Sciences, 23, 670-678. https://doi.org/10.26355/eurrev_201901_16905
|
[15]
|
Zhu, J., Wu, C., Li, H., Yuan, Y., Wang, X., Zhao, T., et al. (2016) DACH1 Inhibits the Proliferation and Invasion of Lung Adenocarcinoma through the Downregulation of Peroxiredoxin 3. Tumor Biology, 37, 9781-9788.
https://doi.org/10.1007/s13277-016-4811-x
|
[16]
|
Liu, Q., Li, A., Yu, S., Qin, S., Han, N., Pestell, R.G., et al. (2018) DACH1 Antagonizes CXCL8 to Repress Tumorigenesis of Lung Adenocarcinoma and Improve Prognosis. Journal of Hematology & Oncology, 11, Article No. 53.
https://doi.org/10.1186/s13045-018-0597-1
|
[17]
|
Feng, Y., Wang, L. and Wang, M. (2018) Alteration of DACH1methylation Patterns in Lung Cancer Contributes to Cell Proliferation and Migration. Biochemistry and Cell Biology, 96, 602-609. https://doi.org/10.1139/bcb-2017-0279
|
[18]
|
Yu, S., Yi, M., Xu, L., Qin, S., Li, A. and Wu, K. (2020) CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-Small Cell Lung Cancer. Frontiers in Oncology, 10, Article No. 1515.
https://doi.org/10.3389/fonc.2019.01515
|
[19]
|
Cao, J., Yan, X.-R., Liu, T., Han, X.-B., Yu, J.-J., Liu, S.-H., et al. (2017) MicroRNA-552 Promotes Tumor Cell Proliferation and Migration by Directly Targeting DACH1 via the Wnt/β-Catenin Signaling Pathway in Colorectal Cancer. Oncology Letters, 14, 3795-3802. https://doi.org/10.3892/ol.2017.6600
|
[20]
|
Xu, H., Zhang, Y., Peña, M.M., Pirisi, L. and Creek, K.E. (2017) Six1 Promotes Colorectal Cancer Growth and Metas tasis by Stimulating Angiogenesis and Recruiting Tumor-Associated Macrophages. Carcinogenesis, 38, 281-292.
https://doi.org/10.1093/carcin/bgw121
|
[21]
|
Cheng, Q., Ning, D., Chen, J., Li, X., Chen, X.-P. and Jiang, L. (2018) SIX1 and DACH1 Influence the Proliferation and Apoptosis of Hepatocellular Carcinoma through Regulating p53. Cancer Biology & Therapy, 19, 381-390.
https://doi.org/10.1080/15384047.2018.1423920
|
[22]
|
Lu, G.-F., Geng, F., Xiao, Z., Chen, Y.-S., Han, Y., You, C.-Y., et al. (2019) MicroRNA-6807-3p Promotes the Tumorigenesis of Glioma by Targeting Downstream DACH1. Brain Research, 1708, 47-57.
https://doi.org/10.1016/j.brainres.2018.12.008
|
[23]
|
Zhang, J., Ren, X., Wang, B., Cao, J., Tian, L. and Liu, M. (2018) Effect of DACH1 on Proliferation and Invasion of Laryngeal Squamous Cell Carcinoma. Head & Face Medicine, 14, Article No. 20.
https://doi.org/10.1186/s13005-018-0177-1
|